These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35083338)

  • 1. The Potential Therapeutic Effect of Orexin-Treated versus Orexin-Untreated Adipose Tissue-Derived Mesenchymal Stem Cell Therapy on Insulin Resistance in Type 2 Diabetic Rats.
    Boushra AF; Mahmoud RH; Ayoub SE; Mohammed RA; Shamardl HA; El Amin Ali AM
    J Diabetes Res; 2022; 2022():9832212. PubMed ID: 35083338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decitabine assists umbilical cord-derived mesenchymal stem cells in improving glucose homeostasis by modulating macrophage polarization in type 2 diabetic mice.
    Gao J; Cheng Y; Hao H; Yin Y; Xue J; Zhang Q; Li L; Liu J; Xie Z; Yu S; Li B; Han W; Mu Y
    Stem Cell Res Ther; 2019 Aug; 10(1):259. PubMed ID: 31426846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ectopic expression of insulin in a type 1 diabetic rat model by injection of manipulated mesenchymal stem cells with an insulin construct driven by a glucose-sensitive promoter in the port vein.
    Mohammad Dezashibi H; Farzad-Mohajeri S; Bandehpour M; Shabani A; Kazemi B
    Cell Biochem Funct; 2023 Dec; 41(8):1412-1421. PubMed ID: 37877623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidative Capacity of Liver- and Adipose-Derived Mesenchymal Stem Cell-Conditioned Media and Their Applicability in Treatment of Type 2 Diabetic Rats.
    Elshemy MM; Asem M; Allemailem KS; Uto K; Ebara M; Nabil A
    Oxid Med Cell Longev; 2021; 2021():8833467. PubMed ID: 33623636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of diabetes mellitus on differentiation of mesenchymal stem cells into insulin-producing cells.
    Badr OI; Kamal MM; El-Maraghy SA; Ghaiad HR
    Biol Res; 2024 May; 57(1):20. PubMed ID: 38698488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the adipose tissue-derived mesenchymal stem cells enriched with melatonin in pancreatic cellular regeneration.
    El Aasar H; Rashed L; El Sadik A; Amer R; Emam H
    Folia Morphol (Warsz); 2022; 81(4):931-941. PubMed ID: 34545556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic diabetic mesenchymal stem cells transplantation in streptozotocin-induced diabetic rat.
    Dong QY; Chen L; Gao GQ; Wang L; Song J; Chen B; Xu YX; Sun L
    Clin Invest Med; 2008 Dec; 31(6):E328-37. PubMed ID: 19032902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: identification of a novel role in improving insulin sensitivity.
    Si Y; Zhao Y; Hao H; Liu J; Guo Y; Mu Y; Shen J; Cheng Y; Fu X; Han W
    Diabetes; 2012 Jun; 61(6):1616-25. PubMed ID: 22618776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effect of N, N-Diphenyl-1,4-phenylenediamine and adipose-derived stem cells coadministration on diabetic cardiomyopathy in type 1 diabetes mellitus-rat model.
    Abd El-Lateef HM; Ali LS; Qahl SH; Binjawhar DN; Fayad E; Alghamdi MA; Altalhi SA; Al-Salmi FA; Shabana ES; Radwan KH; Youssef I; Shaaban S; Rashwan HM; El-Sawah SG
    J Exp Zool A Ecol Integr Physiol; 2024 Jul; 341(6):647-657. PubMed ID: 38594572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-treatment with grape seed extract and mesenchymal stem cells in vivo regenerated beta cells of islets of Langerhans in pancreas of type I-induced diabetic rats.
    Farid A; Haridyy H; Ashraf S; Ahmed S; Safwat G
    Stem Cell Res Ther; 2022 Dec; 13(1):528. PubMed ID: 36544223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells improve cardiac function in diabetic rats by reducing cardiac injury biomarkers and downregulating JAK/STAT/iNOS and iNOS/Apoptosis signaling pathways.
    A-Elgadir TME; Shati AA; Alqahtani SA; Ebrahim HA; Almohaimeed HM; ShamsEldeeen AM; Haidara MA; Kamar SS; Dawood AF; El-Bidawy MH
    Mol Cell Endocrinol; 2024 Sep; 591():112280. PubMed ID: 38797354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with adipose tissue-derived mesenchymal stem cells exerts anti-diabetic effects, improves long-term complications, and attenuates inflammation in type 2 diabetic rats.
    Yu S; Cheng Y; Zhang L; Yin Y; Xue J; Li B; Gong Z; Gao J; Mu Y
    Stem Cell Res Ther; 2019 Nov; 10(1):333. PubMed ID: 31747961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia preconditioning increases the ability of healthy but not diabetic rat-derived adipose stromal/stem cells (ASC) to improve histological lesions of streptozotocin-induced diabetic nephropathy.
    Carmona M; Paco-Meza LM; Ortega R; Cañadillas S; Caballero-Villarraso J; Blanco A; Herrera C
    Pathol Res Pract; 2022 Feb; 230():153756. PubMed ID: 35032832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic microenvironment preconditioning of adipose tissue-derived mesenchymal stem cells enhances their anti-diabetic, anti-long-term complications, and anti-inflammatory effects in type 2 diabetic rats.
    Su W; Yu S; Yin Y; Li B; Xue J; Wang J; Gu Y; Zhang H; Lyu Z; Mu Y; Cheng Y
    Stem Cell Res Ther; 2022 Aug; 13(1):422. PubMed ID: 35986406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tissue origin of human mesenchymal stem cells dictates their therapeutic efficacy on glucose and lipid metabolic disorders in type II diabetic mice.
    Ma Y; Wang L; Yang S; Liu D; Zeng Y; Lin L; Qiu L; Lu J; Chang J; Li Z
    Stem Cell Res Ther; 2021 Jul; 12(1):385. PubMed ID: 34233739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human umbilical cord-derived mesenchymal stem cells elicit macrophages into an anti-inflammatory phenotype to alleviate insulin resistance in type 2 diabetic rats.
    Xie Z; Hao H; Tong C; Cheng Y; Liu J; Pang Y; Si Y; Guo Y; Zang L; Mu Y; Han W
    Stem Cells; 2016 Mar; 34(3):627-39. PubMed ID: 26523620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation of photobiomodulation-preconditioned diabetic stem cells accelerates ischemic wound healing in diabetic rats.
    Ahmadi H; Amini A; Fadaei Fathabady F; Mostafavinia A; Zare F; Ebrahimpour-Malekshah R; Ghalibaf MN; Abrisham M; Rezaei F; Albright R; Ghoreishi SK; Chien S; Bayat M
    Stem Cell Res Ther; 2020 Nov; 11(1):494. PubMed ID: 33239072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of preconditioned adipose-derived mesenchymal stem cells with photobiomodulation for the treatment of diabetic foot ulcers: a systematic review.
    Amini A; Chien S; Bayat M
    Lasers Med Sci; 2022 Apr; 37(3):1415-1425. PubMed ID: 34697696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of combined therapy of mesenchymal stem cells with GLP-1 receptor agonist, exenatide, on early-onset nephropathy induced in diabetic rats.
    Habib HA; Heeba GH; Khalifa MMA
    Eur J Pharmacol; 2021 Feb; 892():173721. PubMed ID: 33159934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats.
    Sun X; Hao H; Han Q; Song X; Liu J; Dong L; Han W; Mu Y
    Stem Cell Res Ther; 2017 Nov; 8(1):241. PubMed ID: 29096724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.